Literature DB >> 15322952

Foreword -- ADHD in the scientific and political context.

Jan K Buitelaar1, Aribert Rothenberger.   

Abstract

The foreword focuses on the three main critical questions within the political debate: (1) Is ADHD a psychiatric disorder? (2) Is there over-diagnosis and overtreatment of ADHD? (3) Are psychostimulants dangerous drugs? After discussing the problems within the context of general scientific and merely European political context, the authors conclude with a positive outlook comprising (1) step-up of research in ADHD, (2) exercised control over diagnosis and treatment, (3) the need for training and continuous personal development for doctors, and (4) Improvement of information to teachers and parents. The presented supplement on "ADHD -- beyond core symptoms. Not only a European perspective" underlines this perspective and reflects a broad spectrum of ADHD-related activities currently underway in Europe while having the worldwide development of the field in mind.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322952     DOI: 10.1007/s00787-004-1001-y

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  20 in total

1.  Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study.

Authors:  Russell A Barkley; Mariellen Fischer; Lori Smallish; Kenneth Fletcher
Journal:  Pediatrics       Date:  2003-01       Impact factor: 7.124

Review 2.  Attention-deficit hyperactivity disorder and hyperkinetic disorder.

Authors:  J M Swanson; J A Sergeant; E Taylor; E J Sonuga-Barke; P S Jensen; D P Cantwell
Journal:  Lancet       Date:  1998-02-07       Impact factor: 79.321

3.  Short-term trends in Dutch children's attention problems.

Authors:  P F de Jong
Journal:  Eur Child Adolesc Psychiatry       Date:  1997-06       Impact factor: 4.785

4.  Psychosis during methylphenidate abuse.

Authors:  J Spensley; D A Rockwell
Journal:  N Engl J Med       Date:  1972-04-20       Impact factor: 91.245

5.  Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample.

Authors:  M L Wolraich; J N Hannah; T Y Pinnock; A Baumgaertel; J Brown
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-03       Impact factor: 8.829

Review 6.  National Institutes of Health Consensus Development Conference Statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD)

Authors: 
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-02       Impact factor: 8.829

7.  Methylphenidate: increased abuse or appropriate use?

Authors:  M E Llana; M L Crismon
Journal:  J Am Pharm Assoc (Wash)       Date:  1999 Jul-Aug

8.  Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men.

Authors:  J L Rapoport; M S Buchsbaum; H Weingartner; T P Zahn; C Ludlow; E J Mikkelsen
Journal:  Arch Gen Psychiatry       Date:  1980-08

9.  Effect of a media blitz and a threatened lawsuit on stimulant treatment.

Authors:  D J Safer; J M Krager
Journal:  JAMA       Date:  1992-08-26       Impact factor: 56.272

10.  Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain.

Authors:  N D Volkow; Y S Ding; J S Fowler; G J Wang; J Logan; J S Gatley; S Dewey; C Ashby; J Liebermann; R Hitzemann
Journal:  Arch Gen Psychiatry       Date:  1995-06
View more
  9 in total

Review 1.  Do the diagnostic criteria for ADHD need to change? Comments on the preliminary proposals of the DSM-5 ADHD and Disruptive Behavior Disorders Committee.

Authors:  David Coghill; Sarah Seth
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-11-25       Impact factor: 4.785

2.  Pathogenesis and pathophysiology of attention-deficit/hyperactivity disorder: from childhood to adulthood.

Authors:  M Gerlach; J Deckert; A Rothenberger; A Warnke
Journal:  J Neural Transm (Vienna)       Date:  2008       Impact factor: 3.575

3.  Selective difficulty in recognising facial expressions of emotion in boys with ADHD. General performance impairments or specific problems in social cognition?

Authors:  Nicola Yuill; Jenny Lyon
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-03-30       Impact factor: 4.785

4.  Predictors of diagnostic delay in a clinical sample of French children with attention-deficit/hyperactivity disorder.

Authors:  D Purper-Ouakil; S Cortese; M Wohl; M Asch; E Acquaviva; B Falissard; G Michel; P Gorwood; M C Mouren
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-14       Impact factor: 4.785

Review 5.  Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management.

Authors:  Johnny Graham; David Coghill
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  Psychometric properties of the parent strengths and difficulties questionnaire in the general population of German children and adolescents: results of the BELLA study.

Authors:  Aribert Rothenberger; Andreas Becker; Michael Erhart; Nora Wille; Ulrike Ravens-Sieberer
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-12       Impact factor: 4.785

7.  REM-sleep alterations in children with co-existence of tic disorders and attention-deficit/hyperactivity disorder: impact of hypermotor symptoms.

Authors:  Roumen Kirov; Tobias Banaschewski; Henrik Uebel; Jörg Kinkelbur; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-06       Impact factor: 4.785

8.  Who cares for patients with attention-deficit/hyperactivity disorder (ADHD)? Insights from Nordbaden (Germany) on administrative prevalence and physician involvement in health care provision.

Authors:  Michael Schlander; Oliver Schwarz; Goetz-Erik Trott; Michael Viapiano; Norbert Bonauer
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-10       Impact factor: 4.785

Review 9.  Current issues around the pharmacotherapy of ADHD in children and adults.

Authors:  Willemijn M Meijer; Adrianne Faber; Els van den Ban; Hilde Tobi
Journal:  Pharm World Sci       Date:  2009-06-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.